alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 35.1

SERVICER COMPLIANCE STATEMENT (Item 1123)

Residential Funding Company, LLC

RALI Series 2007-QS10 Trust (the Issuing Entity)

The undersigned, a duly authorized officer of Residential Funding Company, LLC, as servicer (the Servicer) pursuant to the Series Supplement, dated as of August 1, 2007, and the Standard Terms of Pooling and Servicing
Agreement, dated as of August 1, 2007 (as amended from time to time, the Agreement), among Residential Accredit Loans, Inc., as company, Residential Funding Company, LLC, as master servicer, and Deutsche Bank Trust Company Americas,
as trustee, does hereby certify that:

1. A review of the Servicers activities during the period covered by the Issuing Entitys report on Form
10-K and of the Servicers performance under the Agreement has been made under my supervision.

2. To the best of my knowledge, based on such review,
the Servicer has fulfilled all of its obligations under the Agreement in all material respects throughout such period.

IN WITNESS WHEREOF, the undersigned
has duly executed this Certificate this 24th day of March 2008.



|       |  |                     
|------ |  | --------------------
|By:    |  | /s/ Anthony N. Renzi
|Name:  |  | Anthony N. Renzi    
|Title: |  | Managing Director
Exhibit 10.2  Liberty Alliance, Inc.  Convertible Promissory Note  June 22, 2006$2,500  Liberty Alliance, Inc., a Nevada corporation, (The Company) for value received, hereby promises to pay, on demand, to Rusty Reid, (Note Holder) the principal amount of Two Thousand Five Hundred Dollars ($2,500), together with interest on the unpaid principal balance at the rate of 8% per annum for twenty-four months from the date of this note.  The obligation to make payments provided for in this Note are absolute and unconditional and not subject to any defense, set-off, counterclaim, or adjustment whatsoever. The Company hereby expressly waives demand and presentment for payment, notice of nonpayment, and protest in taking any action to collect the payment of all sums owing hereon.  The Company grants The Note Holder the right to convert the principal and interest outstanding on this Note, (Conversion Right), into Five Hundred Thousand (500,000) Shares of Liberty Alliance, Inc., common stock.  To exercise the Conversion Right the Note Holder shall deliver to The Company in writing, a Conversion Notice. The Conversion Right is available to the Note Holder subsequent to the Company becoming an operating company and no longer classified as a "shell" company under SEC regulations.  In the event of any default hereunder, the Company, hereby agrees to pay to the Note Holder reasonable attorney's fees, legal expenses, and lawful collection costs incurred in connection with the enforcement of this obligation in addition to all other sums due hereunder, regardless of whether litigation is actually commenced. The parties to, and the terms herein of this Note, shall be governed in all respects by the laws of the State of Utah.  The Company acknowledges to the Note Holder that the shares offered have not been registered under the Securities Act of 1933, or any state securities laws, and are to be sold to the Note Holder pursuant to exemptions from registration requirements of the Securities Act of 1933 and applicable state securities laws.  In witness whereof, the Company has caused this Convertible Promissory Note to be executed and dated the day and year first above written.  Liberty Alliance, Inc.  By: /s/ Steven L. White Steven L. White, President
---

Exhibit 32.2

CERTIFICATION PURSUANT TO18 U.S.C. §
1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Carbiz Inc. (the
Company) on Form 10-QSB for the period ended October 31, 2007 as filed with
the Securities and Exchange Commission on the date hereof (the Report), I,
Stanton C. Heintz, Chief Financial Officer of the Company, certify, pursuant to
18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002, that:

| | (1) | The Report fully complies with the requirements of
      Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
  and                                   
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------
| |     |                                                                                                                                                                 
| | (2) | The information contained in the Report fairly presents,
      in all material respects, the financial condition and results of
      operations of the Company.



| | /s/
      Stanton C. Heintz                        | 
| | -------------------------------------------------- | 
| | Stanton C. Heintz                                  | 
| | Chief Financial Officer                            | 
| | (principal financial and accounting
      officer) | 
| | December 17, 2007                                  | 

---
Amendment No. 1 to Executive Employment Agreement - Gerry Wang



 Exhibit 10.4 
 AMENDMENT NO. 1 TO 
 EXECUTIVE EMPLOYMENT AGREEMENT 
 This Amendment No. 1 to Executive Employment Agreement (this “Amendment”) for Gerry Wang
effective as of the 1st day of January, 2009. The capitalized terms used herein shall have the meanings ascribed thereto in the Employment Agreement
(as defined below). 
 BETWEEN: 
 SEASPAN SHIP
MANAGEMENT LTD. 
 AND: 
 GERRY WANG 

 WHEREAS: 
  

	A.	Gerry Wang (the “Executive”) has been employed by Seaspan Ship Management Ltd. (the “Company”) since 2000 and is presently its Chief Executive
Officer (“CEO”). 

  

	B.	On August 8, 2005, the Company entered into an Executive Employment Agreement (the “Employment Agreement”) with the Executive, pursuant to which the Executive
agreed to continue to serve as the CEO of the Company and to serve as CEO of Seaspan Corporation (“SC”). 

  

	C.	The Company and the Executive would like to amend the Employment Agreement as follows. 

 NOW, THEREFORE, in consideration of the terms and conditions set forth below and acting pursuant to Section 9.6 of the Employment Agreement, the Company and the Executive hereby agrees as follows:

  

	1)	The definitions of the terms “Initial Term” and “Renewal Date” in Section 1.1 are hereby amended and restated in their entirety as follows:


 “Initial Term” means the period beginning on the Effective Date and ending on December 31, 2013.

 “Renewal Date” means December 31, 2013 and December 31 of each succeeding year. 
  

	2)	Section 3.1 of the Employment Agreement is hereby amended and restated in its entirety as follows: 

  

 1 








 3.1. Initial Term 
 The initial term of this Agreement will be from the Effective Date to December 31, 2013 (the “Initial Term”). On December 31, 2013 and on December 31 of each succeeding year, this
Agreement will automatically renew and extend for a period of twelve (12) months from the Renewal Date, unless written notice of non-renewal is delivered from one party to the other during the period beginning two hundred ten (210) days
prior to the Renewal Date and concluding one hundred eighty (180) days prior to such Renewal Date. If such written notice of non-renewal is delivered from one party to the other, the employment of the Executive will terminate on
December 31 of the year in which such notice is delivered. 
  

	3)	Governing Law. This Amendment and its application and interpretation will be governed exclusively by the laws of British Columbia and the laws of Canada applicable in British
Columbia. 

  

	4)	Ratification. In all other respects, the Employment Agreement is hereby ratified and confirmed and shall remain in full force and effect. 

 [The remainder of this page is intentionally left blank.] 
  

 2 








 IN WITNESS WHEREOF, the parties hereto have duly executed this Amendment as the date set forth above. 
  

									
	SEASPAN SHIP MANAGEMENT LTD.	 		 	
					
	Per:	 	/s/ Sai W. Chu	 		 		 	/s/ Gerry Wang
		 	Authorized Signatory	 		 		 	GERRY WANG

 SIGNATURE PAGE 
 AMENDMENT NO.1 TO EMPLOYMENT AGREEMENT 
 FOR 
 GERRY
WANG
John Owen KILEY, Appellant, v. STATE of Florida, Appellee.

Case No. 5D17-3314

District Court of Appeal of Florida, Fifth District.

Opinion filed May 10, 2019

Michael Ufferman, of Michael Ufferman Law Firm, P.A., Tallahassee, for Appellant.

Ashley Moody, Attorney General, Tallahassee, and Kaylee D. Tatman, Assistant Attorney General, Daytona Beach, for Appellee.

LAMBERT, J.

John Owen Kiley timely appeals his judgment and ten-year prison sentence for vehicular homicide. He argues that the trial court erred in denying his request for a downward departure sentence.1 Having carefully reviewed the record, we conclude that the trial court did not err in its analysis as to whether or not it had the ability or authority to impose a downward departure sentence in this case. We also hold that the trial court did not abuse its discretion in declining to impose a departure sentence.2*See**Banks v. State* , 732 So. 2d 1065, 1067-68 (Fla. 1999) (holding that the aspect of a trial court's decision as to whether it should impose a downward departure sentence "is a judgment call within the sound discretion of the court and will be sustained on review absent an abuse of discretion"); *accord**Fogarty v. State* , 158 So. 3d 669, 670-71 (Fla. 4th DCA 2014) ; *Barnhill v. State* , 140 So. 3d 1055, 1060 (Fla. 2d DCA 2014).

AFFIRMED.

EVANDER, C.J., and HARRIS, J., concur.

1

Kiley's lowest permissible sentence on his Criminal Punishment Code Scoresheet was 111 months' incarceration (nine years and three months).

2

We acknowledge that previously, in *Little v. State* , 152 So. 3d 770, 771-72 (Fla. 5th DCA 2014), we had stated that an appellate court lacks the authority to review a trial court's discretionary decision to deny a requested downward departure sentence. This statement, however, was not essential to the decision in that case and, being mere dicta, was of no precedential value. *See**State ex rel. Biscayne Kennel Club v. Bd. of Bus. Regulation* , 276 So. 2d 823, 826 (Fla. 1973) (recognizing that a statement in a district court of appeal opinion that was not essential to the decision of the court is obiter dictum and without force as precedent).
EXHIBIT 35.1

Servicer Compliance Certificate

FIFTH THIRD AUTO TRUST 2013-1





The undersigned, a duly authorized
officer of Fifth Third Bank (Fifth Third), an Ohio banking corporation, as servicer (in such capacity, the Servicer) under the Servicing Agreement, dated as of August 21, 2013 (as amended and supplemented,
or otherwise modified and in effect from time to time, the Servicing Agreement), by and among Fifth Third Auto Trust 2013-1, the Servicer and Deutsche Bank Trust Company Americas, as Indenture Trustee, does hereby certify that:



| | 1. | A review of the activities of the Servicer during the period from January 1, 2014 through December 31, 2014 (the Reporting
Period), and of its performance under the Servicing Agreement has been made under my supervision; and
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 2. | To the best of my knowledge, based on such review, the Servicer has fulfilled all of its obligations under the Servicing Agreement in all material
respects throughout the Reporting Period.
| | -- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

[Signature Page Follows]



---

IN WITNESS WHEREOF, the undersigned has duly executed this Certificate on behalf of the Servicer
this 30th day of March, 2015.



FIFTH THIRD BANKBy:

/s/ Nathan SteuberName:

Nathan SteuberTitle:

Vice President
STATE of Louisiana v. Larry R. BROWN, Jr.

NO. 2019-KO-0297

Supreme Court of Louisiana.

June 3, 2019

Denied.
<TABLE> <S> <C>


<ARTICLE>                     5
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                              DEC-31-1998
<PERIOD-START>                                 JAN-01-1998
<PERIOD-END>                                   DEC-31-1998
<CASH>                                           4,628,544  
<SECURITIES>                                             0  
<RECEIVABLES>                                      102,793  
<ALLOWANCES>                                             0  
<INVENTORY>                                        361,467  
<CURRENT-ASSETS>                                 5,261,583  
<PP&E>                                           1,875,808  
<DEPRECIATION>                                     775,748
<TOTAL-ASSETS>                                   7,978,688  
<CURRENT-LIABILITIES>                            1,442,117  
<BONDS>                                            170,903  
<PREFERRED-MANDATORY>                                    0  
<PREFERRED>                                              0  
<COMMON>                                           135,657  
<OTHER-SE>                                       6,230,011  
<TOTAL-LIABILITY-AND-EQUITY>                     7,978,688  
<SALES>                                             76,565  
<TOTAL-REVENUES>                                    76,565  
<CGS>                                               34,863  
<TOTAL-COSTS>                                       34,863  
<OTHER-EXPENSES>                                 7,378,419  
<LOSS-PROVISION>                                         0  
<INTEREST-EXPENSE>                                 (84,256)
<INCOME-PRETAX>                                 (7,252,461) 
<INCOME-TAX>                                             0  
<INCOME-CONTINUING>                             (7,252,461) 
<DISCONTINUED>                                           0  
<EXTRAORDINARY>                                          0  
<CHANGES>                                                0  
<NET-INCOME>                                    (7,252,461) 
<EPS-PRIMARY>                                        (0.55) 
<EPS-DILUTED>                                        (0.55) 
                                               


</TABLE>
Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

        Understanding Over-the-Counter Medicines

Safe Daily Use of Aspirin Home
          Drugs
          Resources | Drugs
          Information for Consumers and Patients | Drugs
          Buying & Using Medicine Safely
          Understanding Over-the-Counter Medicines
          Safe Daily Use of AspirinUnderstanding Over-the-Counter Medicines Safe Daily Use of Aspirin
  	
        Share
    Post
    Linkedin

    Email
    PrintRelated ResourcesAspirin for Reducing Your Risk of Heart Attack and Stroke: Know the Facts (brochure)Before Using Aspirin to Lower Your Risk of Heart Attack or Stroke, Here is What You Should Know (fact sheet)Educational Resources: Understanding Over-the-Counter MedicineAdditional InformationInformation about Taking Ibuprofen and Aspirin TogetherAspirin: Questions and Answers

                                                                                  Content current as of:
      05/17/2018Safe Daily Use of Aspirin
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop
III 

117TH CONGRESS 

2D SESSION S. RES. 539 

Directing the Architect of the Capitol to obtain and place a memorial plaque 

for United States Capitol Police Officer William F. Evans at the north 

security kiosk of the Capitol. 

IN THE SENATE OF THE UNITED STATES 

MARCH 8 (legislative day, MARCH 7), 2022 

Ms. KLOBUCHAR (for herself and Mr. BLUNT) submitted the following 

resolution; which was considered and agreed to 

RESOLUTION 

Directing the Architect of the Capitol to obtain and place 

a memorial plaque for United States Capitol Police Officer William F. Evans at the north security kiosk of 

the Capitol. 

Whereas William ‘‘Billy’’ F. Evans was born on February 18, 

1980 in North Adams, Massachusetts; 

Whereas Officer Billy Evans joined the United States Capitol 

Police on March 7, 2003 and served with distinction in 

the Capitol Division in the First Responder Unit; 

Whereas Officer Billy Evans was protecting the United 

States Capitol on April 2, 2021 when he was run over 

by a driver, who hit Officer Evans and another officer; 

Whereas Officer Billy Evans died on April 2, 2021 in the heroic performance of his duties as a United States Capitol 


kjohnson on DSK79L0C42PROD with BILLS
2 

•SRES 539 ATS 

Police Officer while protecting the Capitol and the Members and staff of, and visitors to, Congress; and 

Whereas Officer Billy Evans lay in honor in the rotunda of 

the Capitol on April 13, 2021: Now, therefore, be it 

1 Resolved, 

2 SECTION 1. MEMORIAL PLAQUE FOR UNITED STATES CAP3 ITOL POLICE OFFICER WILLIAM F. EVANS. 

4 (a) NORTH SECURITY KIOSK PLAQUE.—By not later 

5 than April 2, 2022, the Architect of the Capitol shall ob6 tain a memorial plaque for Officer William ‘‘Billy’’ F. 

7 Evans and place the plaque at the north security kiosk 

8 of the United States Capitol, near the intersection of Dela9 ware Avenue NE and Constitution Avenue NE. 

10 (b) RULES COMMITTEE APPROVAL.—Before the Ar11 chitect of the Capitol may obtain a plaque under sub12 section (a), the Architect of the Capitol shall submit the 

13 plans for the plaque, including the design and text of the 

14 plaque, to the Committee on Rules and Administration of 

15 the Senate for approval by the Chairman and Ranking 

16 Member of the Committee, acting jointly. 

Æ 


kjohnson on DSK79L0C42PROD with BILLS
| 1. | The Bank is Trustee under the Trust Agreement. |
|----|------------------------------------------------|

| 2. | The undersigned is duly authorized as required pursuant to the Trust Agreement to execute and deliver this Certificate to the Trust. |
|----|--------------------------------------------------------------------------------------------------------------------------------------|

| 3. | This Certificate is delivered pursuant to Item 1123 of the Securities and Exchange Commission’s Regulation AB. |
|----|----------------------------------------------------------------------------------------------------------------------|

| 4. | A review of the Trustee’s activities during the twelve-month period ended December 31, 2010 and of its performance under the Trust Agreement has been made under my supervision. |
|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5. | To the best of my knowledge, based on such review, the Trustee has fulfilled all of its obligations under the Trust Agreement in all material respects throughout such twelve-month period. |
|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| By:    | /s/ Janet O’Hara |   |
|--------|------------------------|--------|
| Name:  | Janet O’Hara     |   |
| Title: | Vice President         |   |

----

----
ACCEPTED 04-15-00408-CR FOURTH COURT OF APPEALS SAN ANTONIO, TEXAS 10/1/2015 3:40:40 PM KEITH HOTTLE CLERK
Case 1:17-cv-00559-NJV Document 1-1 Filed 02/03/17 Page 1 of 3
Case 1:17-cv-00559-NJV Document 1-1 Filed 02/03/17 Page 2 of 3
Case 1:17-cv-00559-NJV Document 1-1 Filed 02/03/17 Page 3 of 3
Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

Parent Section N/A Home
          En EspanolHome En Espanol
  
  	
    Share
    Post
    Linkedin

    Email
    Print

                                                                                  Content current as of:
      10/27/2008Parent Section N/A
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop